| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1761485A1 Amidino compounds as cysteine protease inhibitors |
| 03/14/2007 | EP1562936B1 Therapeutic piperazine compounds |
| 03/14/2007 | EP1517895B1 8-(biaryl) quinoline pde4 inhibitors |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | CN1930157A Silylierte carboxamide |
| 03/14/2007 | CN1930156A Oxidized thioether derivatives of styryl-azoles and their use as HER tyrosine kinases inhibitors |
| 03/14/2007 | CN1930155A Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 03/14/2007 | CN1930154A Ether derivatives, their manufacture and use as pharmaceutical agents |
| 03/14/2007 | CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes |
| 03/14/2007 | CN1930144A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 03/14/2007 | CN1930143A MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 03/14/2007 | CN1930138A Substituted morpholine and thiomorpholine derivatives |
| 03/14/2007 | CN1930136A Isoxazoline-substituted benzamide compound and noxious organism control agent |
| 03/14/2007 | CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 03/14/2007 | CN1930133A 苯并咪唑衍生物 Benzimidazole derivatives |
| 03/14/2007 | CN1930124A Process for cross coupling indoles |
| 03/14/2007 | CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection |
| 03/14/2007 | CN1929836A (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 03/14/2007 | CN1929738A Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides |
| 03/14/2007 | CN1929737A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/14/2007 | CN1304416C Heterocyclic tripeptides as hepatitis C inhibitors |
| 03/14/2007 | CN1304394C Diastereomeric selective preparation method of lamivudine |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304378C Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1303996C use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
| 03/13/2007 | US7189858 N-phenyl substituted carbamoyloxyalkyl-azolium derivatives |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
| 03/13/2007 | US7189712 For therapy of hyperproliferative diseases |
| 03/13/2007 | US7189482 Organophotoreceptor with charge transport compound with an azine group |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2274756C Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/13/2007 | CA2264063C Cryptophycin compounds |
| 03/13/2007 | CA2116388C Treatment for viral diseases |
| 03/08/2007 | WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 03/08/2007 | WO2007028118A2 Nicotinic acid and picolinic acid derived near-infrared fluorophores |
| 03/08/2007 | WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007027959A1 Novel benzopyran derivatives as potassium channel openers |
| 03/08/2007 | WO2007027917A2 Lewis acid catalyzed halogenation of activated carbon atoms |
| 03/08/2007 | WO2007027729A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026834A1 Pyrazole derivatives and herbicides for agricultural and horticultural use |
| 03/08/2007 | WO2007026761A1 Thiazole derivative |
| 03/08/2007 | WO2007026097A1 Novel indole compounds |
| 03/08/2007 | WO2007025897A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/08/2007 | WO2007005668A3 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/08/2007 | WO2006137009A3 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents |
| 03/08/2007 | WO2006117307A3 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 03/08/2007 | WO2006067392A3 Indole derivatives for the treatment of tuberculosis |
| 03/08/2007 | US20070055063 Preparation of thiazoles |
| 03/08/2007 | US20070054943 Therapeutic agent for keratoconjunctival disorder |
| 03/08/2007 | US20070054939 N-ethyl-N-(1-methyl-2-oxo-2-phenylethyl)2-[1(4'-trifluoromethylbiphenyl-2-carbonyl)piperid-4-yl]thiazole-4-carbamate ; hypertriglyceridaemia, hypercholesterolaemia, or dyslipidaemia associated with diabetes; microsomal triglyceride transfer protein (MTP), |
| 03/08/2007 | US20070054933 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/08/2007 | US20070054924 Novel piperidines as chemokine modulators (ccr) |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054917 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 03/08/2007 | US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
| 03/08/2007 | US20070054899 Aromatase inhibitor compounds and uses thereof |
| 03/08/2007 | US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 03/08/2007 | US20070054892 Isoquinoline potassium channel inhibitors |
| 03/08/2007 | US20070054881 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/08/2007 | CA2822094A1 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 03/08/2007 | CA2621227A1 Thiazole derivative |
| 03/08/2007 | CA2620894A1 Novel benzopyran derivatives as potassium channel openers |
| 03/08/2007 | CA2620846A1 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 03/08/2007 | CA2620818A1 Amide derivatives as rock inhibitors |
| 03/08/2007 | CA2620688A1 Heterocyclic compound |
| 03/08/2007 | CA2620658A1 Novel indole compounds |
| 03/08/2007 | CA2620352A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | CA2620127A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/08/2007 | CA2620085A1 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 03/08/2007 | CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/07/2007 | EP1760082A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as anti-proliferative compounds |
| 03/07/2007 | EP1760076A1 FAP Inhibitors |
| 03/07/2007 | EP1759698A1 Novel method of treatment |
| 03/07/2007 | EP1758898A1 Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands |
| 03/07/2007 | EP1758895A1 Gonadotropin releasing hormone receptor antagonists |
| 03/07/2007 | EP1758892A1 Compounds and compositions as protein kinase inhibitors |
| 03/07/2007 | EP1758891A2 Benzimidazolone carboxylic acid derivatives |
| 03/07/2007 | EP1758887A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 03/07/2007 | EP1758883A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |